Inyx IncOver The Counter Market:IYXI
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inyx Inc | 50.0 | 0.0x | --- |
Integrated Biopharma Inc | 9.8M | 24.9x | -42.26% |
Health-Chem Corp | 1.2K | 0.0x | --- |
BGM Group Ltd | 50.6M | -6.4x | --- |
China Medicine Corp | 5.6K | 0.0x | --- |
Biofrontera Inc | 4.2M | -0.5x | --- |
Company Information
Inyx, Inc. is a provider of specialty pharmaceutical products and technologies. Its operations are focused on the development of both prescriptions, over the counter pharmaceutical products, and specialty consulting services. Also, the Company utilizes niche drug delivery capabilities to develop its own products. The product and service categories of the Company include Metered Dose Inhalers (MDIs) (CFC & HFA), Dry Powder Inhalers (DPIs), Metered Dose Pump Sprays (nasal and oral), Hydrocarbon Foam Aerosols, Saline Aerosols, Sterile Solutions/Injectables, Solid Dose, Formulation Services, Analytical Development Validation, Stability Services, Regulatory Support and Integrated Project Management.
Contact Information
- Headquarters
- 825 Third Avenue, 40Th Floor,NEW YORK, NY, United States 10022-7592
- Phone
- 212-838-1111
- Fax
- 212-838-0060
Executives
- Chairman of the Board, Chief Executive Officer
- Jack Kachkar
- President
- Steven Handley
- Executive Vice President, Chief Scientific Officer
- Colin Hunter
- Executive Vice President and Director of Corporate Development, Director
- Jay Green
- Vice President of Sales and Marketing and Commercial Development
- Stephen Beckman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.00 |
|---|---|
Revenue (TTM) | $85.0M |
Shares Outstanding | 53.1M |
Inyx Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.79 |
Book Value | $-0.70 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -31.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
